Rongsu Qi is a prominent inventor based in Menlo Park, CA (US). He has made significant contributions to the field of cancer detection through his innovative patents. With a total of 3 patents, Qi's work focuses on improving diagnostic methods for cancer.

Latest Patents

One of his latest patents is centered around methylation markers and a targeted methylation probe panel. This cancer assay panel is designed for the targeted detection of cancer-specific methylation patterns. The patent outlines methods for designing, making, and utilizing this cancer assay panel for effective cancer diagnosis. Another notable patent involves methods and systems for screening for conditions. These methods aim to enhance the positive predictive value for cancer detection using cell-free nucleic acid samples. The approach includes the use of at least two assays, which can differ in sensitivity, specificity, sequencing depth, analyte, and cost. An exemplary method proposed can provide an initial cancer assay with high sensitivity, followed by a follow-up assay with high specificity in detecting cancer.

Career Highlights

Rongsu Qi is currently associated with Grail, Inc., a company dedicated to advancing cancer detection technologies. His work at Grail has positioned him as a key player in the development of innovative diagnostic tools.

Collaborations

Some of his notable coworkers include Srinka Ghosh and Samuel S Gross. Their collaborative efforts contribute to the advancement of cancer detection methodologies.

Conclusion

Rongsu Qi's innovative work in cancer detection technologies showcases his commitment to improving diagnostic methods. His patents reflect a deep understanding of the complexities involved in cancer detection, making significant strides in the field.

This text is generated by artificial intelligence and may not be accurate.